Saturday, February 14, 2026
ADVT 
International

UK PM Johnson to visit India on April 21 to strengthen ties

Darpan News Desk, 20 Apr, 2022 10:45 AM
  • UK PM Johnson to visit India on April 21 to strengthen ties

UK Prime Minister Boris Johnson will pay an official visit to India from April 21-22. This will be his maiden visit to India as Prime Minister, said the Ministry of External Affairs on Sunday.

During the two-day meet, the British Prime Minister will first land in Ahmedabad on April 21 and then proceed to Delhi.

The ministry statement said, "At the invitation of Prime Minister Shri Narendra Modi, the Rt. Hon'ble Boris Johnson MP, Prime Minister of the United Kingdom will pay an official visit to India from 21-22 April 2022. This will be his maiden visit to India as Prime Minister of the United Kingdom."

During the visit, Prime Minister Narendra Modi and the UK PM are likely to discuss trade, defence and the Ukraine crisis.

"The Prime Ministers will review implementation of the Roadmap 2030 and set their vision for further intensifying cooperation across the full spectrum of bilateral ties. They will also exchange views on regional and global issues of mutual interest," said the ministry.

"Prime Minister Johnson will be accorded a ceremonial welcome at Rashtrapati Bhavan and will hold bilateral consultations with the Prime Minister on April 22. Besides official engagements in New Delhi, the Prime Minister of the United Kingdom will also visit Gujarat on April 21.

"India and the United Kingdom enjoy a long and historical relationship which was elevated to a Comprehensive Strategic Partnership during the India-UK Virtual Summit in 2021," said the ministry in a statement.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK